Do you have cholesterol? A lot of this medicine recalled because it contains a tablet of a diabetes medicine

This November 21, the National Agency for the Safety of Medicines and Health Products (ANSM) announces that it is recalling a batch of drugs for the treatment of cholesterol. The cause was a packaging error in one of the bottles.

In its news of November 21, the National Agency for the Safety of Medicines and Health Products (ANSM) announces that it is recalling a batch of vials ofatorvastatin Arrow generic 10 mga treatment for cholesterol. In question, the discovery of a treatment tablet for type 2 diabetes in a bottle.

The ANSM explains that it was informed by the Arrow laboratory of a packaging error in one of the treatments. Indeed, they noted the presence of a Gliclazide 30 mg modified release tablet (hypoglycemic), this is a medication usually used against diabetes. At this time, this packaging error has only been reported for one vial. In addition, this recall does not affect boxes of atorvastatin in blister packs.

— ANSM (@ansm) November 21, 2024

Recall of a batch of medication for the treatment of cholesterol: what you need to know

Also, people having in possession a bottle ofatorvastatin Arrow generic 10 mg of the lot JBM2300810F “are invited to return it to the pharmacy for it to be replaced”. As a reminder, atorvastatin 10 mg is a medication used in the long-term treatment of cholesterol. The ANSM specifies that “the laboratory does not identify any risk of supply tension linked to this recall”.

As the ANSM specifies, “both tablets are white in color, but their shape and engraving are different”. If, for the moment, no cases have been reported, an error in taking this treatment can cause hypoglycemianamely too low blood sugar. It manifests itself in particular by sweating, a feeling of abnormal hunger, nauseatremors, dizziness, headaches or even dizziness.

What should I do if my atorvastatin bottle is affected by this recall?

If you have a bottle of generic atorvastatin Arrow 10 mg from batch JBM2300810F, you must go to the pharmacy so that the pharmacist can check and, if necessary, issue a new box from a compliant batch. The ANSM specifies that if you have a bottle from the batch concerned, “do not stop or change your treatment without medical advice and return your bottle to the pharmacy”.

If you experience symptoms suggestive of hypoglycemia despite taking atorvastatin 10 mg, the ANSM recommends contacting your doctor.

Source :

Recall of a batch of atorvastatin due to the presence of a gliclazide tablet in a bottle – National Agency for the Safety of Medicines and Health Products (ANSM) – 11/21/2024

Journalist for the Health, Love, Children and Slimming sections, I joined the editorial team of Femme Actuelle in February 2023. I am keen to share with you the latest research in health, but also to collect advice from specialists to inform you about the different practices regarding physical activity and nutrition.